Amgen vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026?
Key PointsAmgen maintains a massive global footprint and generated over $8.1 billion in free cash flow during its latest fiscal year.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.